Harrisburg, NC -- (SBWIRE) -- 03/11/2019 -- "Global Dravet Syndrome Market: Industry Analysis & Outlook (2018-2023)", This report tracks the major market events including product launches, development trends, mergers & acquisitions and the innovative business strategies opted by key market players. Along with strategically analyzing the key markets, the report also focuses on industry-specific drivers, restraints, opportunities and challenges in the Dravet Syndrome market.
Key players of the market include Zogenix, Zynerba, GW Pharmaceuticals, and OPKO. Currently, only GW Pharmaceuticals Epidiolex is commercially available. Other players are currently developing their drugs or seeking for commercial approval by FDA and EMA. Zogenix's ZX008 is expected to penetrate market in 2019 and create competition for GW Pharmaceuticals. Currently, the market is dominated by generic drugs.
Purchase A Copy of this Report (USD $800) at:
https://www.marketinsightsreports.com/report/purchase/03071138825?mode=su?source=releasewire&Mode=07
Essential points covered in Global Dravet Syndrome Market 2019 Research are:-
- What will the market size and the growth rate be in 2023?
- What are the key factors driving the Global Dravet Syndrome market?
- What are the key market trends impacting the growth of the Global Dravet Syndrome market?
- What are the challenges to market growth?
- Who are the key vendors in the Global Dravet Syndrome market?
- What are the market opportunities and threats faced by the vendors in the Global Dravet Syndrome market?
- What are the key outcomes of the five forces analysis of the Global Dravet Syndrome market?
This independent 62 pages report guarantees you will remain better informed than your competition. With tables and figures examining the Dravet Syndrome market, the report gives you a visual, one-stop breakdown of the leading products, submarkets and market leader's market revenue forecasts as well as analysis to 2023.
Furthermore, the report provides a detailed analysis of the Global Dravet Syndrome market with analysis of market size by value and volume. Along with this, an analysis of penetration rate and the average revenue generated per user (ARPU) in the market has also been done.
Request a Sample Copy of this Report at:
https://www.marketinsightsreports.com/reports/03071138825/global-dravet-syndrome-market-industry-analysis-outlook-2019-2023/inquiry?source=releasewire&Mode=07
Dravet syndrome, formerly known as severe myoclonic epilepsy of infancy (SMEI), is a severe kind of epilepsy which causes seizures. High fever is usually a trigger for these seizures. It is a rare disorder that affects an estimated 1 in every 20,000-40,000 births. It usually develops in the six month of age. It is caused by loss-of-function mutations in one copy of the SCN1A gene. Patients with Dravet syndrome are not able to produce sufficient levels of functional Nav1.1 sodium channel, preventing inhibitory neurons from firing properly.
The disorder is considered orphan indication. And there are very limited treatment options available in the market. However, several therapeutics for Dravet syndrome are in pipeline. The drugs in development are getting orphan drug designation by FDA and EMA. The Dravet syndrome market in Europe and the U.S. is likely to exhibit significant growth in the next five years due to increasing research and development activities conducted by several companies. Several companies are making alliances for developing therapeutics for Dravet syndrome. Currently, the U.S and Europe are holding the potential growth for Dravet Syndrome market due to increasing R&D into new drug development for Dravet syndrome and approval for these drugs in these regions.
Browse Full Report at:
https://www.marketinsightsreports.com/reports/03071138825/global-dravet-syndrome-market-industry-analysis-outlook-2019-2023?source=releasewire&Mode=07
The research includes historic data from 2014 to 2019 and forecasts until 2023 which makes the report an invaluable resource for company executives, marketing executive, sales and product managers, consultants, analysts, and stakeholders looking for key industry data in readily accessible documents with clearly presented tables and graphs.
The report will make detailed analysis mainly on the development environment, market size, and development trends of Dravet Syndrome market on the basis of current situation of the industry in 2019 so as to get a holistic understanding of the competition in Dravet Syndrome Market Carrier.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
About MarketInsightsReports
MarketInsightsReports provides syndicated Market research reports to industries, organizations or even individuals with an aim of helping them in their decision making process. MarketInsightsReports has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
Contact Us:
Irfan Tamboli (Head of Sales)
Market Insights Reports
Phone: + 1704 266 3234 | Mob: +91-750-707-8687
sales@marketinsightsreports.com | irfan@marketinsightsreports.com